Psoriasis appears to be a risk factor for mortality from all causes in a dose-response manner with disease severity and from several specific causes, suggest the results of a systematic review and meta-analysis.
Overall, 5-fluorouracil is more effective than imiquimod in reducing the risk of keratinocyte carcinoma, but there are no differences in the short- or long-term risk of subsequent site-specific keratinocyte carcinoma in a real-world practice setting, according to a new study.
Immune checkpoint inhibitor therapy may lead to various inflammatory reactions with differing degrees of severity, suggests a recent study. Most rashes respond to topical treatment, but immunotherapy is often interrupted by immunobullous and exfoliative presentations.
The risk of incident thyroid diseases, including hyperthyroidism, hypothyroidism, thyroiditis, Graves disease and Hashimoto thyroiditis, is increased in individuals with psoriatic disease, suggests a study, adding that endocrinology consultation may be considered when thyroid symptoms are present in psoriasis patients.
Compared with cryotherapy and other immunotherapeutic modalities, the most effective therapies for achieving complete primary and distant recovery (along with autoinoculation for distant recovery) and reducing the recurrence rate in patients with warts are purified protein derivative (PPD) and measles, mumps, rubella (MMR) vaccines, suggest the results of a network meta-analysis.
All patients with acne are potentially at risk of scarring. Professor Goh Chee Leok addresses this issue by focussing on preventing the development of scars in his talk at the 41st Annual Meeting of the Dermatological Society of Malaysia held in Kuching, Sarawak.
Olumacostat glasaretil (OG) appears to be effective and is well tolerated in patients with moderate to severe facial acne vulgaris, suggesting the need for further development, according to a new study.
Cost of treatment is a major driver of patients’ primary nonadherence to acne medication, according to a recent study. Physicians who openly discuss medications costs and provide a plan of action in case patients are unable to fill prescriptions may improve treatment adherence.
New topical formulation BiRetix gel Ultra (BR gel) is effective and well tolerated in individuals with mild to moderate acne, reducing both noninflammatory (NI-L) and inflammatory acne lesions (IL), a recent study has found. In addition, BR gel has good skin tolerability and can be considered as first-line treatment for predominant comedonal.